Macquarie Group’s Array Biopharma Inc ARRY Stock Holding History

Macquarie Group’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-2,242,208	Closed	-$104M	–	1974
2019 Q2	$104M	Sell	2,242,208 -203,945	-8%	-$5.73M	0.18%	102
2019 Q1	$59.6M	Buy	2,446,153 +1,430,735	+141%	+$29.8M	0.1%	205
2018 Q4	$14.5M	Buy	1,015,418 +2,581	+0.3%	+$39.1K	0.03%	508
2018 Q3	$15.4M	Buy	1,012,837 +83,159	+9%	+$1.27M	0.03%	544
2018 Q2	$15.6M	Buy	929,678 +127,853	+16%	+$2.03M	0.03%	533
2018 Q1	$13.1M	Buy	801,825 +471,825	+143%	+$7.56M	0.02%	563
2017 Q4	$4.22M	Hold	330,000	–	–	0.01%	817
2017 Q3	$4.06M	Hold	330,000	–	–	0.01%	810
2017 Q2	$2.76M	Hold	330,000	–	–	0.01%	888
2017 Q1	$2.95M	Hold	330,000	–	–	0.01%	877
2016 Q4	$2.9M	Hold	330,000	–	–	0.01%	867
2016 Q3	$2.23M	Hold	330,000	–	–	﹤0.01%	930
2016 Q2	$1.18M	Buy	+330,000	New	+$1.08M	﹤0.01%	1100

Other funds holding ARRY

ASN

Advisory Services Network Atlanta, Georgia $8.83B AUM 38.5% 1-Year Est. Return

Macquarie Group's ARRY Position: Q3 2019 in Review

Macquarie Group sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 2,242,208 shares — an estimated $104M sold.

Macquarie Group first reported a position in ARRY in Q2 2016 and held it in 13 quarters. The position peaked at $104M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

Macquarie Group reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
Macquarie Group sold 2,242,208 Array Biopharma Inc shares in Q3 2019, an estimated $104M.
Macquarie Group first reported a position in Array Biopharma Inc in Q2 2016 and held it in 13 quarters.
Macquarie Group's Array Biopharma Inc position peaked at $104M in Q2 2019.
1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Macquarie Group's 13F filing for Q3 2019, filed 14 Nov 2019.